Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects.

Herman S, Niemelä V, Emami Khoonsari P, Sundblom J, Burman J, Landtblom AM, Spjuth O, Nyholm D, Kultima K.

Sci Rep. 2019 Mar 11;9(1):4129. doi: 10.1038/s41598-019-40186-5.

2.

Interoperable and scalable data analysis with microservices: Applications in Metabolomics.

Emami Khoonsari P, Moreno P, Bergmann S, Burman J, Capuccini M, Carone M, Cascante M, de Atauri P, Foguet C, Gonzalez-Beltran A, Hankemeier T, Haug K, He S, Herman S, Johnson D, Kale N, Larsson A, Neumann S, Peters K, Pireddu L, Rocca-Serra P, Roger P, Rueedi R, Ruttkies C, Sadawi N, Salek RM, Sansone SA, Schober D, Selivanov V, Thévenot EA, van Vliet M, Zanetti G, Steinbeck C, Kultima K, Spjuth O.

Bioinformatics. 2019 Mar 9. pii: btz160. doi: 10.1093/bioinformatics/btz160. [Epub ahead of print]

PMID:
30851093
3.

Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol.

Smyth B, Krishnan AV, Gallagher M, Kiernan M, Snelling P, Hawley C, Fernando M, Hand S, Grimley K, Burman J, Heath A, Kang A, Perkovic V, Jardine MJ.

BMJ Open. 2019 Jan 15;9(1):e023736. doi: 10.1136/bmjopen-2018-023736.

4.

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing⁻Remitting Multiple Sclerosis.

Herman S, Åkerfeldt T, Spjuth O, Burman J, Kultima K.

Cells. 2019 Jan 24;8(2). pii: E84. doi: 10.3390/cells8020084.

5.

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.

Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB.

JAMA. 2019 Jan 15;321(2):165-174. doi: 10.1001/jama.2018.18743.

PMID:
30644983
6.

Digital methods can help you . . . If you're careful, critical, and not historiographically naïve.

Burman JT.

Hist Psychol. 2018 Nov;21(4):297-301. doi: 10.1037/hop0000112.

PMID:
30421946
7.

Intrathecal treatment trial of rituximab in progressive MS: An open-label phase 1b study.

Bergman J, Burman J, Gilthorpe JD, Zetterberg H, Jiltsova E, Bergenheim T, Svenningsson A.

Neurology. 2018 Nov 13;91(20):e1893-e1901. doi: 10.1212/WNL.0000000000006500. Epub 2018 Oct 10.

PMID:
30305449
8.

Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis.

Herman S, Khoonsari PE, Tolf A, Steinmetz J, Zetterberg H, Åkerfeldt T, Jakobsson PJ, Larsson A, Spjuth O, Burman J, Kultima K.

Theranostics. 2018 Aug 7;8(16):4477-4490. doi: 10.7150/thno.26249. eCollection 2018.

9.

Parkin and PINK1 mitigate STING-induced inflammation.

Sliter DA, Martinez J, Hao L, Chen X, Sun N, Fischer TD, Burman JL, Li Y, Zhang Z, Narendra DP, Cai H, Borsche M, Klein C, Youle RJ.

Nature. 2018 Sep;561(7722):258-262. doi: 10.1038/s41586-018-0448-9. Epub 2018 Aug 22.

PMID:
30135585
10.

Container-based bioinformatics with Pachyderm.

Novella JA, Emami Khoonsari P, Herman S, Whitenack D, Capuccini M, Burman J, Kultima K, Spjuth O.

Bioinformatics. 2019 Mar 1;35(5):839-846. doi: 10.1093/bioinformatics/bty699.

11.

High arachis hypogaea allergen 2 immunoglobulin E levels predict responses to exposure to a small amount of peanut protein.

Burman J, Kukkonen AK, Pelkonen AS, Mäkelä MJ.

Acta Paediatr. 2018 Dec;107(12):2216. doi: 10.1111/apa.14511. Epub 2018 Aug 14. No abstract available.

PMID:
30043419
12.

Mitochondrial quality control mechanisms as molecular targets in cardiac ageing.

Picca A, Mankowski RT, Burman JL, Donisi L, Kim JS, Marzetti E, Leeuwenburgh C.

Nat Rev Cardiol. 2018 Sep;15(9):543-554. doi: 10.1038/s41569-018-0059-z. Review.

PMID:
30042431
13.

Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?

Berntsson SG, Kristoffersson A, Boström I, Feresiadou A, Burman J, Landtblom AM.

Acta Neurol Scand. 2018 Oct;138(4):327-331. doi: 10.1111/ane.12963. Epub 2018 May 24.

PMID:
29797711
14.

Treatment of epilepsy in multiple sclerosis.

Dagiasi I, Vall V, Kumlien E, Burman J, Zelano J.

Seizure. 2018 May;58:47-51. doi: 10.1016/j.seizure.2018.04.001. Epub 2018 Apr 5.

PMID:
29656097
15.

Risk of epilepsy after a single seizure in multiple sclerosis.

Mahamud Z, Burman J, Zelano J.

Eur J Neurol. 2018 Jun;25(6):854-860. doi: 10.1111/ene.13618. Epub 2018 Apr 6.

PMID:
29512931
16.

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.

Niemelä V, Burman J, Blennow K, Zetterberg H, Larsson A, Sundblom J.

PLoS One. 2018 Feb 23;13(2):e0193492. doi: 10.1371/journal.pone.0193492. eCollection 2018.

17.

Through the looking-glass: PsycINFO as an historical archive of trends in psychology.

Burman JT.

Hist Psychol. 2018 Nov;21(4):302-333. doi: 10.1037/hop0000082. Epub 2018 Feb 5.

PMID:
29400480
18.

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.

Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic Z, Burman J, Moore J, Rovira M, Wulffraat NM, Kazmi M, Greco R, Snarski E, Kozak T, Kirgizov K, Alexander T, Bader P, Saccardi R, Farge D; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP); EBMT Paediatric Working Party (PWP); Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT); EBMT (JACIE).

Blood Adv. 2017 Dec 20;1(27):2742-2755. doi: 10.1182/bloodadvances.2017010041. eCollection 2017 Dec 26.

19.

Epilepsy in multiple sclerosis: A nationwide population-based register study.

Burman J, Zelano J.

Neurology. 2017 Dec 12;89(24):2462-2468. doi: 10.1212/WNL.0000000000004740. Epub 2017 Nov 8.

PMID:
29117950
20.

Blogs cannot separate wheat from chaff.

Burt RK, Snowden JA, Burman J, Oliveira MC, Sharrack B.

Science. 2017 Nov 3;358(6363):602. doi: 10.1126/science.aar2575. No abstract available.

PMID:
29097540
21.

Regioselective Intermolecular Allylic C-H Amination of Disubstituted Olefins via Rhodium/π-Allyl Intermediates.

Burman JS, Blakey SB.

Angew Chem Int Ed Engl. 2017 Oct 23;56(44):13666-13669. doi: 10.1002/anie.201707021. Epub 2017 Oct 4.

PMID:
28913956
22.

Mitochondrial fission facilitates the selective mitophagy of protein aggregates.

Burman JL, Pickles S, Wang C, Sekine S, Vargas JNS, Zhang Z, Youle AM, Nezich CL, Wu X, Hammer JA, Youle RJ.

J Cell Biol. 2017 Oct 2;216(10):3231-3247. doi: 10.1083/jcb.201612106. Epub 2017 Sep 11.

23.

Autologous haematopoietic stem cell transplantation for neurological diseases.

Burman J, Tolf A, Hägglund H, Askmark H.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):147-155. doi: 10.1136/jnnp-2017-316271. Epub 2017 Sep 2. Review.

24.

Eucapnic voluntary hyperventilation test in children.

Burman J, Lukkarinen H, Elenius V, Remes S, Kuusela T, Jartti T.

Clin Physiol Funct Imaging. 2018 Jul;38(4):718-720. doi: 10.1111/cpf.12458. Epub 2017 Aug 7.

PMID:
28782910
25.

Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.

Paužuolis M, Eich T, Burman J.

PLoS One. 2017 Jun 6;12(6):e0179095. doi: 10.1371/journal.pone.0179095. eCollection 2017.

26.

Autologous hematopoietic stem cell transplantation for MS: Safer than previously thought.

Burman J, Fox RJ.

Neurology. 2017 May 30;88(22):2072-2073. doi: 10.1212/WNL.0000000000003995. Epub 2017 Apr 28. No abstract available.

PMID:
28455384
27.

Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Burman J, Kirgizov K, Carlson K, Badoglio M, Mancardi GL, De Luca G, Casanova B, Ouyang J, Bembeeva R, Haas J, Bader P, Snowden J, Farge D.

Bone Marrow Transplant. 2017 Aug;52(8):1133-1137. doi: 10.1038/bmt.2017.40. Epub 2017 Mar 20.

PMID:
28319075
28.

Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab.

Fagius J, Feresiadou A, Larsson EM, Burman J.

Mult Scler Relat Disord. 2017 Feb;12:82-87. doi: 10.1016/j.msard.2017.01.009. Epub 2017 Jan 24.

PMID:
28283113
29.

Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society.

Vågberg M, Axelsson M, Birgander R, Burman J, Cananau C, Forslin Y, Granberg T, Gunnarsson M, von Heijne A, Jönsson L, Karrenbauer VD, Larsson EM, Lindqvist T, Lycke J, Lönn L, Mentesidou E, Müller S, Nilsson P, Piehl F, Svenningsson A, Vrethem M, Wikström J.

Acta Neurol Scand. 2017 Jan;135(1):17-24. doi: 10.1111/ane.12667. Epub 2016 Aug 24. Review.

30.

YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

Burman J, Raininko R, Blennow K, Zetterberg H, Axelsson M, Malmeström C.

J Neuroimmunol. 2016 Mar 15;292:52-7. doi: 10.1016/j.jneuroim.2016.01.013. Epub 2016 Jan 22.

PMID:
26943959
31.

Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

Burman J, Svenningsson A.

J Neuroimmunol. 2016 Mar 15;292:40-4. doi: 10.1016/j.jneuroim.2016.01.008. Epub 2016 Jan 16.

PMID:
26943957
32.

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial.

Rystedt A, Zetterberg L, Burman J, Nyholm D, Johansson A.

Clin Neuropharmacol. 2015 Sep-Oct;38(5):170-6. doi: 10.1097/WNF.0000000000000101.

PMID:
26366966
33.

The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy.

Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI, Youle RJ.

Nature. 2015 Aug 20;524(7565):309-314. doi: 10.1038/nature14893. Epub 2015 Aug 12.

34.

On the Meanings of Self-Regulation: Digital Humanities in Service of Conceptual Clarity.

Burman JT, Green CD, Shanker S.

Child Dev. 2015 Sep-Oct;86(5):1507-21. doi: 10.1111/cdev.12395. Epub 2015 Jul 31.

PMID:
26234744
35.

Searching for the structure of early American psychology: Networking Psychological Review, 1909-1923.

Green CD, Feinerer I, Burman JT.

Hist Psychol. 2015 May;18(2):196-204. doi: 10.1037/a0039013.

PMID:
26120920
36.

Neglect of the foreign invisible: Historiography and the navigation of conflicting sensibilities.

Burman JT.

Hist Psychol. 2015 May;18(2):146-69. doi: 10.1037/a0039194.

PMID:
26120918
37.

Hearing the inaudible experimental subject: Echoes of Inaudi, Binet's calculating prodigy.

Burman JT, Guida A, Nicolas S.

Hist Psychol. 2015 Feb;18(1):47-68. doi: 10.1037/a0038448.

PMID:
25664885
38.

Searching for the structure of early American psychology: Networking Psychological Review, 1894-1908.

Green CD, Feinerer I, Burman JT.

Hist Psychol. 2015 Feb;18(1):15-31. doi: 10.1037/a0038406.

PMID:
25664883
39.

Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.

Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K, Yaung K, Helenowski IB, Jovanovic B, Spahovic D, Arnautovic I, Lee DC, Benefield BC, Futterer S, Oliveira MC, Burman J.

JAMA. 2015 Jan 20;313(3):275-84. doi: 10.1001/jama.2014.17986.

PMID:
25602998
40.

The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention.

Burman J, Svensson E, Fransson M, Loskog AS, Zetterberg H, Raininko R, Svenningsson A, Fagius J, Mangsbo SM.

J Neuroimmunol. 2014 Dec 15;277(1-2):153-9. doi: 10.1016/j.jneuroim.2014.10.005. Epub 2014 Oct 18.

PMID:
25457841
41.

Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).

Snarski E, Snowden JA, Oliveira MC, Simoes B, Badoglio M, Carlson K, Burman J, Moore J, Rovira M, Clark RE, Saiz A, Hadj-Khelifa S, Tan J, Crescimanno A, Musso M, Martin T, Farge D.

Bone Marrow Transplant. 2015 Feb;50(2):216-20. doi: 10.1038/bmt.2014.248. Epub 2014 Nov 10.

PMID:
25387098
42.

A Drosophila model of mitochondrial disease caused by a complex I mutation that uncouples proton pumping from electron transfer.

Burman JL, Itsara LS, Kayser EB, Suthammarak W, Wang AM, Kaeberlein M, Sedensky MM, Morgan PG, Pallanck LJ.

Dis Model Mech. 2014 Oct;7(10):1165-74. doi: 10.1242/dmm.015321. Epub 2014 Aug 1.

43.

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party.

Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D.

Mult Scler. 2015 Feb;21(2):189-97. doi: 10.1177/1352458514541978. Epub 2014 Jul 30.

PMID:
25078274
44.

Beyond the schools of psychology 2: a digital analysis of psychological review, 1904-1923.

Green CD, Feinerer I, Burman JT.

J Hist Behav Sci. 2014 Summer;50(3):249-79. doi: 10.1002/jhbs.21665. Epub 2014 Jun 9.

PMID:
24911464
45.

PINK1-Parkin pathway activity is regulated by degradation of PINK1 in the mitochondrial matrix.

Thomas RE, Andrews LA, Burman JL, Lin WY, Pallanck LJ.

PLoS Genet. 2014 May 29;10(5):e1004279. doi: 10.1371/journal.pgen.1004279. eCollection 2014.

46.

Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis.

Fransson M, Piras E, Wang H, Burman J, Duprez I, Harris RA, LeBlanc K, Magnusson PU, Brittebo E, Loskog AS.

Immunology. 2014 Jul;142(3):431-41. doi: 10.1111/imm.12275.

47.

Assessing tissue damage in multiple sclerosis: a biomarker approach.

Burman J, Zetterberg H, Fransson M, Loskog AS, Raininko R, Fagius J.

Acta Neurol Scand. 2014 Aug;130(2):81-9. doi: 10.1111/ane.12239. Epub 2014 Feb 24.

PMID:
24571714
48.

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P, Vrethem M, Fredrikson S, Martin C, Sandstedt A, Uggla B, Lenhoff S, Johansson JE, Isaksson C, Hägglund H, Carlson K, Fagius J.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21. doi: 10.1136/jnnp-2013-307207. Epub 2014 Feb 19.

PMID:
24554104
49.

Normal outcome of pregnancy with ongoing treatment with natalizumab.

Fagius J, Burman J.

Acta Neurol Scand. 2014 Jun;129(6):e27-9. doi: 10.1111/ane.12222. Epub 2014 Feb 15.

PMID:
24527849
50.

Using Sex Pheromone and a Multi-Scale Approach to Predict the Distribution of a Rare Saproxylic Beetle.

Musa N, Andersson K, Burman J, Andersson F, Hedenström E, Jansson N, Paltto H, Westerberg L, Winde I, Larsson MC, Bergman KO, Milberg P.

PLoS One. 2013 Jun 19;8(6):e66149. doi: 10.1371/journal.pone.0066149. Print 2013.

Supplemental Content

Loading ...
Support Center